A letter for each compound × outcome, drawn from randomised trials and meta-analyses — with effect size and every caveat spoken plainly. The preclinical never poses as proven.
How we grade →Every production batch will be tested by an independent house, and each result verifiable by its task number — with a blind retest available on request.
Reading a COA →Named reviewers and fact-checkers. Funding disclosed. We never grade upward what we might profit to sell — that severance is the whole point.
For compounds eligible through a licensed pharmacy, we point you to legitimate access as information — never a grey checkout. Dosing is a clinician's call, never a product page.
The reference does not sell. The shop does not grade. Keeping the two apart is what lets either be trusted.
A compound's grade is written from the published evidence by named reviewers with no stake in its sale. Whether we can offer it to you is a separate, lawful-lane decision made per region — a cosmetic carries a price; a research compound carries only a follow.
No dosing, reconstitution, or administration guidance is published for research compounds anywhere on this site. That restraint is deliberate.
A neutral reference and a lawful-lane shop. Registered in Spain. Information for those who seek it — never promotion.
This site provides neutral scientific reference and sells only products lawful in your region. Nothing here is medical advice, a recommendation, or an offer to supply unapproved medicines. No dosing or administration is published for research compounds. Cosmetic peptides per Regulation (EC) 1223/2009. Unapproved injectable peptides are neither sold nor advertised in the EU (Directive 2001/83/EC, Title VIII). © 2026 Vallydia SL — Registered in Spain.